Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research?
Fowler, PA, Sorsa-Leslie, T, Harris, W, Mason, HD
Published in Reproduction (Cambridge, England) (01.12.2003)
Published in Reproduction (Cambridge, England) (01.12.2003)
Get full text
Journal Article
Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles
Martinez, Francisca, Barri, P.N., Coroleu, B., Tur, R., Sorsa-Leslie, Tarja, Harris, William J., Groome, Nigel P., Knight, Philip G., Fowler, Paul A.
Published in Human reproduction (Oxford) (01.03.2002)
Published in Human reproduction (Oxford) (01.03.2002)
Get full text
Journal Article
A 60–66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells
Fowler, Paul A., Sorsa-Leslie, Tarja, Cash, Phillip, Dunbar, Bryan, Melvin, William, Wilson, Yvonne, Mason, Helen D., Harris, William
Published in Molecular human reproduction (01.09.2002)
Published in Molecular human reproduction (01.09.2002)
Get full text
Journal Article
Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay
Sorsa-Leslie, Tarja, Mason, Helen D, Harris, William J, Fowler, Paul A
Published in Reproductive biology and endocrinology (26.09.2005)
Published in Reproductive biology and endocrinology (26.09.2005)
Get full text
Journal Article